Samuel Whiting - Net Worth and Insider Trading
Samuel Whiting Net Worth
The estimated net worth of Samuel Whiting is at least $9,189 dollars as of 2024-11-29. Samuel Whiting is the Chief Medical Officer of Tempest Therapeutics Inc and owns about 9,573 shares of Tempest Therapeutics Inc (TPST) stock worth over $9,189. Details can be seen in Samuel Whiting's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Samuel Whiting has not made any transactions after 2024-07-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Samuel Whiting
Samuel Whiting Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Samuel Whiting owns 1 companies in total, including Tempest Therapeutics Inc (TPST) .
Click here to see the complete history of Samuel Whiting’s form 4 insider trades.
Insider Ownership Summary of Samuel Whiting
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TPST | Tempest Therapeutics Inc | 2024-07-02 | Chief Medical Officer |
Samuel Whiting Latest Holdings Summary
Samuel Whiting currently owns a total of 1 stock. Samuel Whiting owns 9,573 shares of Tempest Therapeutics Inc (TPST) as of July 2, 2024, with a value of $9,189.
Latest Holdings of Samuel Whiting
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TPST | Tempest Therapeutics Inc | 2024-07-02 | 9,573 | 0.96 | 9,189 |
Holding Weightings of Samuel Whiting
Samuel Whiting Form 4 Trading Tracker
According to the SEC Form 4 filings, Samuel Whiting has made a total of 2 transactions in Tempest Therapeutics Inc (TPST) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Tempest Therapeutics Inc is the acquisition of 4,672 shares on July 2, 2024, which cost Samuel Whiting around $9,951.
Insider Trading History of Samuel Whiting
- 1
Samuel Whiting Trading Performance
GuruFocus tracks the stock performance after each of Samuel Whiting's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Samuel Whiting is -24.15%. GuruFocus also compares Samuel Whiting's trading performance to market benchmark return within the same time period. The performance of stocks bought by Samuel Whiting within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Samuel Whiting's insider trading performs compared to the benchmark.
Performance of Samuel Whiting
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -24.52 | | | | | |
| Relative Return to S&P 500(%) | -20.96 | | | | | |
Samuel Whiting Ownership Network
Samuel Whiting Owned Company Details
What does Tempest Therapeutics Inc do?
Who are the key executives at Tempest Therapeutics Inc?
Samuel Whiting is the Chief Medical Officer of Tempest Therapeutics Inc. Other key executives at Tempest Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , director & Chief Executive Officer Stephen R Brady , and Corporate Controller Justin Trojanowski .
Tempest Therapeutics Inc (TPST) Insider Trades Summary
Over the past 18 months, Samuel Whiting made 1 insider transaction in Tempest Therapeutics Inc (TPST) with a net purchase of 4,672. Other recent insider transactions involving Tempest Therapeutics Inc (TPST) include a net sale of 787,999 shares made by Versant Venture Capital Vi, L.p. , a net purchase of 35,000 shares made by Stephen R Brady ,
In summary, during the past 3 months, insiders sold 0 shares of Tempest Therapeutics Inc (TPST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 787,999 shares of Tempest Therapeutics Inc (TPST) were sold and 39,672 shares were bought by its insiders, resulting in a net sale of 748,327 shares.
Tempest Therapeutics Inc (TPST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tempest Therapeutics Inc Insider Transactions
Samuel Whiting Mailing Address
Above is the net worth, insider trading, and ownership report for Samuel Whiting. You might contact Samuel Whiting via mailing address: C/o Tempest Therapeutics, Inc., 7000 Shoreline Court, Suite 275, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
